The generation of these iPSC lines provides a cellular model for translational research and precision medicine in Long QT Syndrome Type 2.
Long QT Syndrome Type 2 (LQT2) is a heart rhythm disorder caused by a loss-of-function mutation in the KCNH2 gene, characterized by a prolonged QT interval on an electrocardiogram (ECG) and symptoms such as syncope and potentially life-threatening Torsades de Pointes arrhythmia. We derived three induced pluripotent stem cell (iPSC) lines from a LQT2 family: two individuals with LQT2 who carry the pathogenic variant c.209A > G (p.His70Arg), and one healthy individual. These iPSC lines exhibit normal karyotype, differentiation capability, stem cell pluripotency, and stem cell morphology, providing a model that can contribute to the fields of translational research and precision medicine.
Scislowicz et al. (Wed,) studied this question.